Warfarin is a widely used oral anticoagulant medicine and rodenticide which antagonizes vitamin K dependent-Gamma-carboxylation of specific N-terminal glutamate residues in at least six essential coagulation factors including factor II (prothrombin), VII, IX, and X. Glutamate Gamma-carboxylation in proteins of a number of other tissues such as developing bone, kidney, lung and placenta is also dependent upon vitamin K. Recently warfarin was shown to exhibit anticancer activity in animal models and in man which can be related to its antivitamin K activity. The ultimate goal of this project is to determine the molecular bases for the antivitamin K activity of warfarin. Determination of the metabolic pathways utilized by vitamin K, which are essential to its Gamma-carboxylation activity, is a further, associated goal of the project.
The specific aims of this proposal are: 1) to purify the 14 to 17,000 dalton protein involved in vitamin K and vitamin K 2,3-epoxide (KO) metabolism and identify whether the catalytically active disulfide is in a prosthetic group or is formed by sulfhydryl containing amino acids; 2) to determine if warfarin binding to the 14 to 17,000 dalton protein is its physiologically relevant site of action; 3) to identify and purify other enzymes and proteins that participate in vitamin K and vitamin KO metabolism and study them in reconstituted systems; and 4) to ascertain the physiologic reductant for the vitamin K and vitamin KO metabolizing enzymes. Protein and enzyme isolation will be accomplished by combinations of electrophoretic, high performance liquid chromatography (HPLC), and conventional and affinity chromatographic techniques. Physiologically relevant sites of warfarin action will be determined by comparison of its affinity for proteins isolated from warfarin-sensitive and resistant rats. Effects of various cofactors and recombination techniques on the rates of vitamin K and vitamin KO metabolism will be assessed by HPLC. Results obtained from these investigations will resolve the outstanding questions concerning the number of enzymes involved in vitamin K and vitamin KO metabolism, the nature of their catalyticaly active groups, and the factors regulating their inhibition by warfarin. Ultimately they will aid in the rational design of better, more specific antivitamin K drugs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL019772-08
Application #
3335937
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1977-01-01
Project End
1990-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
8
Fiscal Year
1986
Total Cost
Indirect Cost
Name
New York State Department of Health
Department
Type
DUNS #
002436061
City
Menands
State
NY
Country
United States
Zip Code
12204
Trivedi, L S; Rhee, M; Galivan, J H et al. (1988) Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation. Arch Biochem Biophys 264:67-73
Fasco, M J; Eagan, G E; Wilson, A C et al. (1988) Loss of metastatic and primary tumor factor X activator capabilities by Lewis lung carcinoma cells cultured in vitamin K-dependent protein deficient serum. Cancer Res 48:6504-9
Fasco, M J; Wilson, A C; Lincoln, D et al. (1987) Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells. Int J Cancer 39:631-7
Fasco, M J; Wilson, A C; Briggs, R G et al. (1987) Identification of vitamin K1 chromenol--a novel metabolite of vitamin K1 formed in vitro by a component in blood. Arch Biochem Biophys 252:501-6
Wilson, A C; Fasco, M J (1986) Vitamin-K-dependent proteins in microsomes of primary Lewis lung tumors. Int J Cancer 38:877-82
Beaune, P H; Kremers, P G; Kaminsky, L S et al. (1986) Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes. Drug Metab Dispos 14:437-42
Lee, J J; Principe, L M; Fasco, M J (1985) Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction. Biochemistry 24:7063-70
Kaminsky, L S; Guengerich, F P (1985) Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin. Eur J Biochem 149:479-89